Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.7941
-0.0132 (-1.64%)
At close: Aug 13, 2025, 4:00 PM
0.8000
+0.0059 (0.74%)
Pre-market: Aug 14, 2025, 9:07 AM EDT
Klotho Neurosciences Market Cap
Klotho Neurosciences has a market cap or net worth of $41.85 million as of August 14, 2025. Its market cap has increased by 88.17% in one year.
Market Cap
41.85M
Enterprise Value
43.05M
1-Year Change
88.17%
Ranking
Category
Stock Price
0.79
Market Cap Chart
Since April 29, 2022, Klotho Neurosciences's market cap has decreased from $127.33M to $41.85M, a decrease of -67.13%. That is a compound annual growth rate of -28.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 42.55M | 312.57% |
| Dec 31, 2024 | 10.31M | -89.05% |
| Dec 22, 2023 | 94.18M | -37.22% |
| Dec 20, 2022 | 150.02M | 17.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |